MS-553 - MingSight Pharma
Breyanzi (lisocabtagene maraleucel) - BMS
Imbruvica (ibrutinib) - AbbVie, J&J
Rituxan (rituximab) - Roche
Venclexta (venetoclax) - Roche, AbbVie
surovatamig (AZD0486) - AstraZeneca
nemtabrutinib (MK-1026) - Merck (MSD)
Jaypirca (pirtobrutinib) - Eli Lilly
bendamustine - Generic mfg.
Epkinly (epcoritamab-bysp) - Genmab, AbbVie
NVG-111 - Novalgen
zelebrudomide (NX-2127) - Nurix Therap
bexobrutideg (NX-5948) - Nurix Therap
ABBV-101 - AbbVie
Brukinsa (zanubrutinib) - BeOne Medicines
AC676 - Accutar Biotech
Lunsumio (mosunetuzumab-axgb) - Roche
catadegbrutinib (BGB-16673) - BeOne Medicines
https://clml-25-01.elsevierdigitaledition.com/
 
Meghan C. Thompson, MD* 1
 
Aug 26, 2025
 
Next